Accessed through the Hayes Knowledge Center, the Evidence Analysis Solution addresses the following fundamental questions to help our clients determine coverage positions:
Focus of the Report: This Health Technology Assessment focuses on the efficacy and safety of the CardioMEMS implantable hemodynamic monitor (CM-IHM) (Abbott) as an adjunct to the management of patients with heart failure (HF).
Technology Description: The CM-IHM system utilizes an impla…
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of ganglion impar block (GIB) or radiofrequency thermocoagulation (RFT) of the ganglion impar to treat chronic pain in adults with chronic coccydynia.
Technology Description:
Focus of the Report: This Health Technology Assessment focuses on anti-infliximab (IFX) antibody (ATI) testing in patients who are undergoing IFX treatment for Crohn disease (CD). This testing is a type of therapeutic drug monitoring (TDM) that is performed to help determine whether ongoing treatment is safe and effective and whether changes …
Focus of the Report: This Health Technology Assessment focuses on the use of the Woven EndoBridge (WEB) aneurysm embolization system, an intrasaccular flow disruption device, for the treatment of intracranial aneurysms (IAs).
Technology Description: T…
Focus of the Report: This Health Technology Assessment focuses on use of bronchial thermoplasty (BT) as an adjunct treatment for severe persistent asthma that remains symptomatic despite medical management with inhaled corticosteroids (ICS) and long-acting beta2 agonists (LABAs).
Technology …
Focus of the Report: This Health Technology Assessment focuses on percutaneous pulmonary valve implantation (PPVI) with Edwards Sapien 3 or Sapien XT valves for the treatment of right ventricular outflow tract (RVOT) defects.
Technology Description: The goal of PPVI is to improve hemodynamics, cardiopulmonary function, and survival while delaying the n…
Focus of the Report: This Health Technology Assessment (HTA) focuses on the use of the Micra transcatheter pacing system (TPS) (Medtronic Inc.) as a leadless alternative to traditional transvenous pacemakers (TVPMs) for the management of patients with bradycardia or atrioventricular (AV) block in the presence or absence of atrial fibrillation…
Focus of the Report: This Health Technology Assessment focuses on the use of functional electrical stimulation (FES) for treatment of foot drop in patients who have a history of stroke an average of ≥ 1 year prior to FES treatment. This mean 1-year threshold was implemented to ensure that the majority of enrolled patients within each study we…
Focus of the Report: This Health Technology Assessment focuses on the use of functional electrical stimulation (FES) for treatment of foot drop in patients who have a history of stroke < 1 year prior to FES treatment. A mean 1-year threshold was implemented to ensure that the majority of enrolled patients within each study were was in the acu...
Focus of the Report: This report focuses on percutaneous peripheral nerve stimulation (PNS) therapy utilizing an external pulse generator for the treatment of adults with intractable chronic pain (pain persisting for ≥ 3 months).
Technology Description: Percutaneous PNS is a nonpharmac…